Title:
INFLUENZA VACCINES CONTAINING HEMAGGLUTININ AND MATRIX PROTEINS
Document Type and Number:
Japanese Patent JP2014205712
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To provide influenza vaccines containing hemagglutinin and matrix proteins.SOLUTION: An immunogenic composition comprising influenza virus haemagglutinin and matrix proteins is provided. These may be from influenza viruses grown in cell culture rather than eggs. The matrix protein may be a fragment of a full-length viral matrix protein e.g. a matrix M1 fragment with a molecular weight of less than 20kDa. The composition may be a subunit vaccine comprising purified surface glycoproteins.
Inventors:
MICHAEL BROEKER
HOLGER KOST
HOLGER KOST
Application Number:
JP2014154488A
Publication Date:
October 30, 2014
Filing Date:
July 30, 2014
Export Citation:
Assignee:
NOVARTIS VACCINES & DIAGNOSTIC
International Classes:
A61K39/145; A61K38/00; A61K38/36; A61P31/16; A61P37/04; G01N33/53; G01N33/569
Attorney, Agent or Firm:
Shusaku Yamamoto
Natsuki Morishita
Natsuki Morishita